Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Glaxo Wellcome describes new agents for CMV

Sep. 29, 1997

Schering-Plough and Genome Therapeutics enter antifungal alliance

Sep. 26, 1997

Phase III trial of Neuprex in meningococcemia continues; pilot trial in CF begins

Sep. 25, 1997

LY-303366: efficacy in rabbits with invasive pulmonary aspergillosis

Sep. 25, 1997

Famvir approved by FDA for new indication

Sep. 22, 1997

Vaxar: first launch for new fluoroquinolone

Sep. 22, 1997

Phase I results reported for MiKasome

Sep. 22, 1997

New cephalosporins from Il-Dong

Sep. 19, 1997

Searle evaluates novel target for antifungal agents

Sep. 17, 1997

Antiviral benzimidazole compounds prepared at Glaxo Wellcome

Sep. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...